» Articles » PMID: 33477341

Extracellular Vesicles in Comorbidities Associated with Ischaemic Heart Disease: Focus on Sex, an Overlooked Factor

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Jan 22
PMID 33477341
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EV) are emerging early markers of myocardial damage and key mediators of cardioprotection. Therefore, EV are becoming fascinating tools to prevent cardiovascular disease and feasible weapons to limit ischaemia/reperfusion injury. It is well known that metabolic syndrome negatively affects vascular and endothelial function, thus creating predisposition to ischemic diseases. Additionally, sex is known to significantly impact myocardial injury and cardioprotection. Therefore, actions able to reduce risk factors related to comorbidities in ischaemic diseases are required to prevent maladaptive ventricular remodelling, preserve cardiac function, and prevent the onset of heart failure. This implies that early diagnosis and personalised medicine, also related to sex differences, are mandatory for primary or secondary prevention. Here, we report the contribution of EV as biomarkers and/or therapeutic tools in comorbidities predisposing to cardiac ischaemic disease. Whenever possible, attention is dedicated to data linking EV to sex differences.

Citing Articles

Research progress of exosomes from different sources in myocardial ischemia.

Yan H, Ding H, Xie R, Liu Z, Yang X, Xie L Front Cardiovasc Med. 2024; 11:1436764.

PMID: 39350967 PMC: 11440518. DOI: 10.3389/fcvm.2024.1436764.


Mechanisms and therapeutic strategies of extracellular vesicles in cardiovascular diseases.

Li Q, Feng Q, Zhou H, Lin C, Sun X, Ma C MedComm (2020). 2023; 4(6):e454.

PMID: 38124785 PMC: 10732331. DOI: 10.1002/mco2.454.


Extracellular Vesicles and Ischemic Cardiovascular Diseases.

Zhu Y, Wang S, Chen X Adv Exp Med Biol. 2023; 1418:57-68.

PMID: 37603272 DOI: 10.1007/978-981-99-1443-2_4.


Ageing-associated small RNA cargo of extracellular vesicles.

Kern F, Kuhn T, Ludwig N, Simon M, Groger L, Fabis N RNA Biol. 2023; 20(1):482-494.

PMID: 37498213 PMC: 10376918. DOI: 10.1080/15476286.2023.2234713.


Association of ACE gene polymorphisms with in-stent restenosis by stent type (biomime, supraflex, xience).

Klashami Z, Roudbordeh M, Asadi M, Ebrahimi P, Amoli M Mol Biol Rep. 2023; 50(8):6445-6455.

PMID: 37328581 DOI: 10.1007/s11033-023-08554-7.


References
1.
Crisafulli A, Pagliaro P, Roberto S, Cugusi L, Mercuro G, Lazou A . Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning. Int J Mol Sci. 2020; 21(8). PMC: 7215312. DOI: 10.3390/ijms21082896. View

2.
Favaro E, Carpanetto A, Caorsi C, Giovarelli M, Angelini C, Cavallo-Perin P . Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients. Diabetologia. 2015; 59(2):325-33. DOI: 10.1007/s00125-015-3808-0. View

3.
Thery C, Witwer K, Aikawa E, Alcaraz M, Anderson J, Andriantsitohaina R . Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2019; 7(1):1535750. PMC: 6322352. DOI: 10.1080/20013078.2018.1535750. View

4.
Kassi E, Pervanidou P, Kaltsas G, Chrousos G . Metabolic syndrome: definitions and controversies. BMC Med. 2011; 9:48. PMC: 3115896. DOI: 10.1186/1741-7015-9-48. View

5.
Perrino C, Ferdinandy P, Botker H, Brundel B, Collins P, Davidson S . Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res. 2020; 117(2):367-385. PMC: 7820844. DOI: 10.1093/cvr/cvaa155. View